Scrip Dividend Declaration

RNS Number : 8295X

Assura PLC

10 January 2022

 

10 January 2022

Assura plc

Scrip Dividend Declaration

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that, pursuant to its Scrip Dividend Scheme and in response to the scrip dividend alternative for the quarterly interim dividend payable on 12 January 2022 (the "Scrip Dividend Alternative"), elections were received in respect of 10 per cent. of the Company's ordinary shares in issue as at the record date of 10 December 2021.

Electing shareholders will receive ordinary shares in the Company ("Shares") in lieu of cash in respect of this dividend and, accordingly 3,286,937 Shares (the "New Shares") will be issued by the Company to such shareholders.

Application has therefore been made for the admission of the New Shares to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 12 January 2022.

Following the allotment of the New Shares, it is expected that the total number of shares in issue will be 2,948,359,637 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 2,948,359,637.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism ( https://data.fca.org.uk/#/nsm/nationalstoragemechanism ).

This interim dividend is 100% Ordinary Dividend (non-PID).

Forms to register for gross PIDs (on future interim dividends) are available on the Company's website. Please click here for PID Forms .

- ENDS -

For more information, please contact:

Assura plc	Tel: [phone]
Orla Ball, Company Secretary David Purcell, Head of Investor Relations	Email: [e-mail]
Finsbury Gordon Simpson James Thompson	Tel: [phone] Email: [e-mail]

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2021, Assura's property portfolio was valued at 2,595 million.

Further information is available at www.assuraplc.com

* EPRA is a registered trademark of the European Public Real Estate Association

Assura plc LEI code: 21380026T19N2Y52XF72

 

END

 

 

DIVBLGDBCBGDGDR